CD8A and glioblastoma: ICOVIR17 treatment increased the infiltration of CD8+ T cells, promoted M1-polarization of TAMs, and induced the expression of PD-L1 in GBM cells. Moreover, ICOVIR17 showed synergistic effects with PD-1 blockade, resulting in increased survival rates in mice-bearing tumors